Is there a role of tranexamic acid in rheumatoid arthritis with total knee arthroplasty? Findings from a multicenter prospective cohort study in China
- PMID: 33386441
- DOI: 10.1007/s00402-020-03709-8
Is there a role of tranexamic acid in rheumatoid arthritis with total knee arthroplasty? Findings from a multicenter prospective cohort study in China
Abstract
Background: Tranexamic acid (TXA) has proven to be effective in reducing the blood loss associated with total knee arthroplasty (TKA) in patients with osteoarthritis. However, there still exists a paucity of evidence regarding the effectiveness of intravenous TXA in patients with rheumatoid arthritis. The aim of this study was to explore the efficacy and safety of intravenous TXA on blood loss after TKA in Chinese patients with rheumatoid arthritis.
Materials and methods: A total of 405 patients with rheumatoid arthritis who had undergone TKA were categorized into two groups based on the protocol of TXA use. TXA group (n = 248): patients received 15 mg/kg TXA prior to operation. Control group (n = 157): patients received no TXA. The outcome measurements such as, total blood loss (TBL), intraoperative blood loss (IBL), hidden blood loss (HBL), transfusion, drainage, the timing of first ambulation, the length of stay (LOS), total hospitalization costs, the results of 12-Item Short Form Survey (SF-12), the incidence of thromboembolic events and other complications were recorded and compared.
Results: The mean TBL, IBL, HBL, volume of transfusion and drainage were significantly lower in TXA group than in Control group. The rate of transfusion was significantly lower in TXA group than in Control group. There was a favorable effect in early ambulation for patients in TXA group, compared with patients in Control group. In addition, TXA group had shorter LOS, lower hospitalization costs and higher postoperative SF-12 score than Control group. The incidence of deep venous thrombosis and other complications did not differ between the two groups.
Conclusion: TXA can effectively diminish blood loss, reduce transfusion, shorten LOS and decrease hospitalization costs after TKA in Chinese patients with rheumatoid arthritis, without increasing the risk of complications.
Keywords: Blood loss; Rheumatoid arthritis; Total knee arthroplasty; Tranexamic acid; Transfusions.
Similar articles
-
The efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study.BMC Musculoskelet Disord. 2023 May 15;24(1):379. doi: 10.1186/s12891-023-06485-9. BMC Musculoskelet Disord. 2023. PMID: 37189066 Free PMC article.
-
The efficacy and safety of tranexamic acid for reducing blood loss following simultaneous bilateral total knee arthroplasty: a multicenter retrospective study.BMC Musculoskelet Disord. 2019 Jul 12;20(1):325. doi: 10.1186/s12891-019-2692-z. BMC Musculoskelet Disord. 2019. PMID: 31299945 Free PMC article.
-
[Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].Acta Chir Orthop Traumatol Cech. 2016;83(4):254-262. Acta Chir Orthop Traumatol Cech. 2016. PMID: 28026726 Czech.
-
Comparing efficacy and safety of 2 methods of tranexamic acid administration in reducing blood loss following total knee arthroplasty: A meta-analysis.Medicine (Baltimore). 2016 Dec;95(50):e5583. doi: 10.1097/MD.0000000000005583. Medicine (Baltimore). 2016. PMID: 27977593 Free PMC article.
-
The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.BMC Musculoskelet Disord. 2018 Sep 7;19(1):321. doi: 10.1186/s12891-018-2181-9. BMC Musculoskelet Disord. 2018. PMID: 30193586 Free PMC article. Review.
Cited by
-
The Optimal Dose, Efficacy and Safety of Tranexamic Acid and Epsilon-Aminocaproic Acid to Reduce Bleeding in TKA: A Systematic Review and Bayesian Network Meta-analysis.Orthop Surg. 2023 Apr;15(4):930-946. doi: 10.1111/os.13678. Epub 2023 Mar 6. Orthop Surg. 2023. PMID: 36878889 Free PMC article.
-
The efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study.BMC Musculoskelet Disord. 2023 May 15;24(1):379. doi: 10.1186/s12891-023-06485-9. BMC Musculoskelet Disord. 2023. PMID: 37189066 Free PMC article.
References
-
- Goh GS, Bin Abd Razak HR, Tay DK, Lo NN, Yeo SJ (2020) Early post-operative oxford knee score and knee society score predict patient satisfaction 2 years after total knee arthroplasty. Arch Orthop Trauma Surg. https://doi.org/10.1007/s00402-020-03612-2 - DOI - PubMed
-
- Xie J, Ma J, Yao H, Yue C, Pei F (2016) Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplasty. https://doi.org/10.1016/j.arth.2016.04.034 - DOI - PubMed
-
- Lei Y, Xie J, Xu B, Xie X, Huang Q, Pei F (2017) The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop 41(10):2053–2059 - PubMed
-
- Ogbemudia AE, Yee SY, MacPherson GJ, Manson LM, Breusch SJ (2013) Preoperative predictors for allogenic blood transfusion in hip and knee arthroplasty for rheumatoid arthritis. Arch Orthop Trauma Surg 133(9):1315–1320 - PubMed
-
- Wu C, Tan C, Wang L (2020) Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty. Arch Orthop Trauma Surg. https://doi.org/10.1007/s00402-020-03591-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials